14-day Premium Trial Subscription Try For FreeTry Free

Information

6310 Town Square, Suite 400

Alpharetta GA 30005

678 990 5740

alimerasciences.com

Alimera Sciences

Description

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Click to get the best stock tips daily for free!
ABOUT ALIMERA SCIENCES
Alimera Sciences
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affectin...
GOLDEN STAR
Ticker Change Signal Date
TYL
$581.55
0.0034% Oct 03
FN
$234.13
3.49% Oct 03
NTAP
$122.71
0.95% Oct 03
VET
$9.77
6.86% Sep 30
FSK
$19.73
1.47% Sep 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE